Johnson & Johnson Announces U.S. CDC Advisory Committee Recommends First Single-Shot COVID-19 Vaccine for Adults 18 and Older in U.S.

NEW BRUNSWICK, N.J., Feb. 28, 2021 /PRNewswire/ —¬†Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee ‚Ķ [read more]

Leave a Comment